首页> 外文期刊>Journal of the American College of Cardiology >Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
【24h】

Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.

机译:支架置入术与冠状动脉旁路移植术治疗未保护的左主冠状动脉疾病后的长期结果:ASAN-MAIN的裸金属支架10年结果和药物洗脱支架的5年结果(ASAN医疗中心-左MAIN血运重建)注册表。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: This study sought to evaluate the long-term safety and effectiveness of percutaneous coronary intervention (PCI), as compared with coronary artery bypass grafting (CABG), for unprotected left main coronary artery (LMCA) disease. BACKGROUND: Data on the long-term (beyond 5-year) comparative results of treatment of unprotected LMCA disease with stent implantation or CABG are limited. METHODS: We performed a 10-year clinical follow-up of 350 patients with unprotected LMCA disease who underwent PCI with bare-metal stents (BMS) (n = 100) or CABG (n = 250) from January 1995 to April 1999, and 5-year clinical follow-up of 395 patients with unprotected LMCA disease who underwent PCI with drug-eluting stents (DES) (n = 176) or CABG (n = 219) from January 2003 to May 2004. The primary safety end points were all-cause mortality and the composite of death, Q-wave myocardial infarction (MI), or stroke, and the primary efficacy end point was target vessel revascularization (TVR). RESULTS: In the 10-year follow-up cohort of BMS and concurrent CABG, the adjusted risks of death (hazard ratio [HR]: 0.81; 95% confidence interval [CI]: 0.44 to 1.50; p = 0.50) and the composite of death, Q-wave MI, or stroke (HR: 0.92; 95% CI: 0.55 to 1.53; p = 0.74) were similar between the 2 groups. The rate of TVR was significantly higher in the group that received BMS (HR: 10.34; 95% CI: 4.61 to 23.18; p < 0.001). In the 5-year follow-up cohort of DES and concurrent CABG, there was no significant difference in the adjusted risk of death (HR: 0.83; 95% CI: 0.34 to 2.07; p = 0.70) or the risk of the composite outcome (HR: 0.91; 95% CI: 0.45 to 1.83; p = 0.79). The rates of TVR were also higher in the DES group than the CABG group (HR: 6.22; 95% CI: 2.26 to 17.14; p < 0.001). CONCLUSIONS: For the treatment of unprotected LMCA disease, PCI with stent implantation showed similar long-term mortality and rates of death, Q-wave MI, or stroke. However, stenting, even with DES, was associated with higher rates of repeat revascularization than was CABG.
机译:目的:本研究旨在评估经皮冠状动脉介入治疗(PCI)与冠状动脉搭桥术(CABG)相比,对于未保护的左主冠状动脉(LMCA)疾病的长期安全性和有效性。背景:关于支架植入或CABG治疗未保护的LMCA疾病的长期(5年以上)比较结果的数据有限。方法:从1995年1月至1999年4月,我们对350例未保护的LMCA病患者进行了为期10年的临床随访,他们接受了裸金属支架(BMS)(n = 100)或CABG(n = 250)的PCI手术,自2003年1月至2004年5月,对395例未保护的LMCA病患者进行了5年临床随访,这些患者接受了药物洗脱支架(DES)(n = 176)或CABG(n = 219)的PCI治疗。主要安全终点为全因死亡率和死亡,Q波心肌梗死(MI)或中风的综合,主要疗效终点是靶血管血运重建(TVR)。结果:在BMS和并发CABG的10年随访队列中,调整后的死亡风险(危险比[HR]:0.81; 95%置信区间[CI]:0.44至1.50; p = 0.50)和综合两组的死亡,Q波心梗或卒中的发生率(HR:0.92; 95%CI:0.55至1.53; p = 0.74)相似。在接受BMS的患者中,TVR的发生率明显更高(HR:10.34; 95%CI:4.61至23.18; p <0.001)。在DES和并发CABG的5年随访队列中,调整后的死亡风险(HR:0.83; 95%CI:0.34至2.07; p = 0.70)或综合结局风险无显着差异。 (HR:0.91; 95%CI:0.45至1.83; p = 0.79)。 DES组的TVR发生率也高于CABG组(HR:6.22; 95%CI:2.26至17.14; p <0.001)。结论:对于未保护的LMCA疾病,PCI支架植入术显示了相似的长期死亡率和死亡率,Q波心肌梗死或中风率。但是,即使使用DES,也比CABG支架置入术的血管再通率更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号